Combination of tissue and liquid biopsy molecular profiling to detect transformation to small cell lung carcinoma during osimertinib treatment

BACKGROUND: Histological transformation of advanced non-small cell lung cancer (NSCLC) to small cell lung cancer (SCLC) is one of the mechanisms of resistance to third-generation tyrosine kinase inhibitors (TKIs), such as osimertinib. This acquired TKI resistance is linked to the high degree of tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Vendrell, Julie A., Quantin, Xavier, Serre, Isabelle, Solassol, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750569/
https://www.ncbi.nlm.nih.gov/pubmed/33414847
http://dx.doi.org/10.1177/1758835920974192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750569/
https://www.ncbi.nlm.nih.gov/pubmed/33414847
http://dx.doi.org/10.1177/1758835920974192

Ejemplares similares